TUDOR INVESTMENT CORP ET AL - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,601,196
+61626.9%
39,025
-46.2%
0.02%
-52.5%
Q1 2023$2,594
+88.8%
72,577
+99.6%
0.04%
+48.1%
Q4 2022$1,374
-99.9%
36,365
+72.3%
0.03%
+35.0%
Q3 2022$934,000
-66.0%
21,109
-71.5%
0.02%
-72.2%
Q2 2022$2,747,000
+151.1%
74,192
+151.3%
0.07%
+176.9%
Q1 2022$1,094,000
-79.8%
29,525
-83.4%
0.03%
-71.4%
Q4 2021$5,428,000
-19.7%
178,386
-11.5%
0.09%
-17.3%
Q3 2021$6,762,000
+69.7%
201,613
+101.8%
0.11%
+46.7%
Q2 2021$3,984,000
+88.1%
99,886
+123.7%
0.08%
-18.5%
Q3 2020$2,118,000
+287.9%
44,644
+286.7%
0.09%
+87.8%
Q1 2020$546,000
-41.7%
11,546
-20.8%
0.05%
+81.5%
Q2 2019$937,000
+354.9%
14,576
+475.2%
0.03%
+200.0%
Q1 2019$206,000
-71.0%
2,534
-80.7%
0.01%
-35.7%
Q4 2018$710,000
+234.9%
13,135
+44.3%
0.01%
+250.0%
Q2 2016$212,0009,1000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders